Optimizing treatment for HER2-positive HR-positive breast cancer

Debien, V; de Azambuja, E; Piccart-Gebhart, M

Piccart-Gebhart, M (通讯作者)，Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Dept, Rue Meylemeersch 90, B-1070 Anderlecht, Belgium.

CANCER TREATMENT REVIEWS, 2023; 115 ():

Abstract

Triple-positive breast tumors overexpress human epidermal growth factor receptor 2 (HER2) and are positive for hormone receptor (HR) expression. Data ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索